Acrospire Investment Management LLC - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 34 filers reported holding CANCER GENETICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q1 2017$45,000
+400.0%
11,090
+69.3%
0.04%
+825.0%
Q4 2016$9,000
+28.6%
6,549
+86.4%
0.00%
-20.0%
Q2 2016$7,0003,5140.01%
Other shareholders
CANCER GENETICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 22,203$148,0002.90%
Millrace Asset Group, Inc. 187,184$1,250,0001.30%
Sterneck Capital Management, LLC 60,650$405,0000.24%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$560,0000.15%
Quality Growth Management, Inc. 23,500$157,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$334,0000.05%
DIKER MANAGEMENT LLC 35,015$234,0000.05%
SSI INVESTMENT MANAGEMENT LLC 65,043$434,0000.04%
BANK OF MONTREAL /CAN/ 616,430$4,118,0000.01%
Commonwealth Equity Services, Inc 27,100$181,0000.00%
View complete list of CANCER GENETICS INC shareholders